[Google Scholar] 23.Flier J.S
It stores itself inside fat cells to prevent fat storage and induce fat loss over time
PlexusDx enables granular selectioncompounded semaglutide, tirzepatide, microdose GLP-1 protocol, or dual-compound GLP-Squaredbased on genetic predispositions, comorbidity status, and provider preference
Moreover, Tirzepatide also slows gastric emptying, contributing to appetite suppression and significant weight loss
This proposes a 6-month implementation phase, followed by rollout over 3 years to 220 000 people, specifically those with BMI 40 kg/m 2 and three or more weight-related comorbidities, followed by those with the same BMI and two and one weight-related comorbidities, respectively
Because the starting dose is low, initial weight changes are typically modest and vary significantly depending on your hydration, nutrition, and baseline metabolism